Ono Pharmaceutical Co. Ltd. (ON4) - Financials, balance sheet (annual)

9.25 EUR

0.25

2.78%

Last update May 16, 7:31 PM CEST

Market closed

Day range

9.25

9.10000

9.25

Previous close

Open

9.10000

Access this stock data via API

Ono Pharmaceutical Co. Ltd.

9.25

0.25

2.78%

Financials

Balance sheet

Fiscal date	2024	2023	2022	2021
Total assets	913.7B	882.4B	739.2B	745.4B
Current assets	413.6B	345.1B	281.3B	247.6B
Cash	—	—	—	—
Cash equivalents	—	—	—	—
Cash and cash equivalents	166.1B	96.1B	69.1B	61.0B
Other short term investments	38.5B	68.2B	47.9B	43.9B
Accounts receivable	136.1B	114.4B	99.8B	84.3B
Other receivables	—	—	—	—
Inventory	48.6B	44.8B	41.8B	39.2B
Prepaid assets	—	—	—	—
Restricted cash	—	—	—	—
Assets held for sale	—	—	—	—
Hedging assets	—	—	—	—
Other current assets	24.3B	21.6B	22.7B	19.2B
Non current assets	500.1B	537.3B	457.9B	497.8B
Properties	—	—	—	—
Land and improvements	—	—	—	—
Machinery furniture equipment	—	—	—	—
Construction in progress	—	—	—	—
Leases	—	—	—	—
Accumulated depreciation	—	—	—	—
Goodwill	57.3B	69.1B	64.7B	68.3B
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	57.3B	69.1B	64.7B	68.3B
Investments and advances	—	—	—	—
Other non current assets	2.8B	3.3B	3.2B	2.6B
Total liabilities	115.1B	134.6B	77.5B	105.7B
Current liabilities	103.6B	122.9B	65.9B	93.7B
Accounts payable	60.7B	66.8B	49.7B	39.2B
Accrued expenses	—	—	—	—
Short term debt	2.3B	2.5B	2.3B	2.0B
Deferred revenue	—	—	—	—
Tax payable	22.1B	34.6B	1.5B	19.0B
Pensions	—	—	—	—
Other current liabilities	16.3B	18.4B	11.7B	12.2B
Non current liabilities	11.4B	11.7B	11.6B	12.0B
Long term provisions	—	—	—	—
Long term debt	6.6B	6.7B	6.5B	7.0B
Provision for risks and charges	—	—	—	—
Deferred liabilities	1.0B	983M	1.0B	1.1B
Derivative product liabilities	—	—	—	—
Other non current liabilities	580M	684M	771M	814M
Shareholders equity
Common stock	17.4B	17.4B	17.4B	17.4B
Retained earnings	768.2B	709.9B	644.8B	582.0B
Other shareholders equity	—	—	—	—
Total shareholders equity	798.6B	747.8B	661.7B	639.7B
Additional paid in capital	17.5B	17.1B	17.2B	17.2B
Treasury stock	63.2B	54.2B	74.7B	44.7B
Minority interest	5.6B	5.9B	5.8B	5.6B